Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics(clinical),General Medicine
Reference143 articles.
1. Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015;14:420–34.
2. Zhang Y, Dai Y, Han JN, Chen ZH, Ling L, Pu CQ, Cui LY, Huang XS. A novel AGRN mutation leads to congenital Myasthenic syndrome only affecting limb-girdle muscle. Chin Med J. 2017;130:2279–82.
3. Bestue-Cardiel M, Natera-de BD. Current status of congenital myasthenic syndromes. Rev Neurol. 2017;65:161–76.
4. Gomez CM, Gammack JT. A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology. 1995;45:982–5.
5. Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B, Beyring R, Robb S, Kirkham FJ, Engel AG. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A. 2001;98:2017–22.
Cited by
135 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献